MarketPeel
Insider Trading Intelligence
JA

John Ackerman

GRDN
DIRECTOR · GUARDIAN PHARMACY SERVICES, INC. · CIK 0002037898
FILING MIX · LIFETIME40%/60%
BUYS
8
SELLS
12
TOTAL VALUE
$58.67M
COMPANIES
1
ACTIVE SINCE
Sep 2024
HOLDINGS NOW
471,057
AVG SELL PX
$24.56
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by John Ackerman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%-1.30%+0.45%-1.75%-1.87%
14d5+80.00%-3.79%+1.96%-5.75%-8.33%
30d5+80.00%-0.94%+5.11%-6.04%-4.95%
60d5+80.00%-3.62%+8.07%-13.30%-13.30%
90d5+0.00%+19.77%+10.23%+9.54%+9.85%
180d5(1 pending)+0.00%+31.65%+13.45%+18.20%+18.20%
1y5(1 pending)+0.00%+77.14%+25.57%+48.81%+48.81%
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GRDN · 471,057 shares · as of Mar 28, 2026
01,413,9402,827,8794,241,8195,655,75820252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
FLOW · 8 buys / 12 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
1,413,9391,413,939Mar 28, 2026Mar 31, 2026View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASE
471,057816,180Mar 28, 2026Mar 31, 2026View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASE
1,413,9392,449,867Mar 28, 2026Mar 31, 2026View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
471,057471,057Mar 28, 2026Mar 31, 2026View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
827,636$29.68$24.57M1,035,928Mar 20, 2026Mar 24, 2026View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
275,728$29.68$8.18M345,123Mar 20, 2026Mar 24, 2026View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASE
1,413,9401,863,564Sep 27, 2025Sep 30, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
471,057942,114Sep 27, 2025Sep 30, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
1,413,9402,827,878Sep 27, 2025Sep 30, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASE
471,057620,851Sep 27, 2025Sep 30, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
50,305$20.16$1.01M149,794May 28, 2025May 29, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
150,998$20.16$3.04M449,624May 28, 2025May 29, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
270,958$20.16$5.46M200,099May 27, 2025May 29, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
813,318$20.16$16.40M600,622May 27, 2025May 29, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
471,0571,413,171Mar 28, 2025Apr 1, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASE
471,057471,057Mar 28, 2025Apr 1, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
SALE
1,413,9404,241,818Mar 28, 2025Apr 1, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASE
1,413,9401,413,940Mar 28, 2025Apr 1, 2025View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASEGRANT
Stock grant
1,884,2281,884,228Sep 27, 2024Oct 1, 2024View →
GRDN
GUARDIAN PHARMACY SERVICES, INC.
PURCHASEGRANT
Stock grant
5,655,7585,655,758Sep 27, 2024Oct 1, 2024View →
Other insiders · GRDN
Loading peer insiders…
About this filer
CIK 0002037898
ROLE
Director
PRIMARY
GRDN
COMPANIES
1
ACTIVE SINCE
Sep 2024
MARKETPEEL · /INSIDER/0002037898DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback